David V. Gauvin, Joshua Yoder, Rachel L. Tapp, Phaedra I. Cole, & Phaedra I. Cole. (2016). Defining “Best Practices” for Critical Endpoints in Preclinical Screening of New Chemical Entities for Ototoxicity Liability. Otolaryngology, 2(2), 58–69. Retrieved from https://openventio.us/index.php/OOJ/article/view/2437